Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07203690

Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
7,000 (estimated)
Sponsor
Henan Cancer Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical study is to conduct a multi-center, big data study to create a neural network decision model for predicting treatment efficacy and prognosis based on multi-modal, multi-temporal imaging features combined with tumor microenvironment scores. It will also use various model interpretation techniques to clarify the role and mechanism of key biomarkers or strongly associated biomarker groups in treatment efficacy and prognosis. Ultimately, it aims to achieve the research and application of AI treatment strategies combining multi-modal imaging and digital pathology to guide clinicians in the personalized treatment strategies for patients with esophageal squamous cell carcinoma.

Conditions

Timeline

Start date
2025-12-01
Primary completion
2027-01-31
Completion
2027-12-01
First posted
2025-10-02
Last updated
2025-10-02

Source: ClinicalTrials.gov record NCT07203690. Inclusion in this directory is not an endorsement.

Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and (NCT07203690) · Clinical Trials Directory